Antibiotic treatment in community and hospital acquired pneumonia complicated by Clostridium difficile infection. Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018
The relationship between ureaplasma spp. and the development of chronic lung disease of prematurity: a survey of senior neonatologists Source: Annual Congress 2007 - Chronic lung disease of prematurity: pathogenesis and outcomes Year: 2007
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients Source: Eur Respir J, 52 (2) 1701190; 10.1183/13993003.01190-2017 Year: 2018
Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey Source: Eur Respir J, 51 (5) 1702469; 10.1183/13993003.02469-2017 Year: 2018
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor Source: Eur Respir J 2004; 24 : 779-785 Year: 2004
Incidence and risk factors of MRSA pneumonia Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011
Identifying risk factors in health care-associated pneumonia (HCAP) patients: nursing home (NH) residency vs. other risk factors Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
Pneumonia and Clostridium difficile infection: Hospital acquired infection in a non-ICU department Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012
Prevalence of nosocomial pneumonia in patients of the general surgical departments Source: Eur Respir J 2003; 22: Suppl. 45, 335s Year: 2003
Risk factors for MRSA staphylococcal carriage in children with chronic allergic diseases Source: Eur Respir J 2006; 28: Suppl. 50, 265s Year: 2006
Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients Source: Eur Respir J 2011; 38: 643-648 Year: 2011
Do prognostic factors help physicians in predicting legionellosis‘ respiratory complications? Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011
Predictive factors for true bacteremia and clinical utility of blood cultures as a prognostic tool in patients with community-onset pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017
Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009
The risk factors in asthma patients for COVID19 infection Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Factors related to obtain an etiological diagnosis in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007
Factors associated with hospital mortality in community-acquired legionellosis in France Source: Eur Respir J 2012; 39: 963-970 Year: 2012
Risk factors for bacterial infection in exacerbated COPD requiring admission Source: Eur Respir J 2001; 18: Suppl. 33, 153s Year: 2001
Predicting bacteraemia or rapid identification of the causative pathogen in community acquired pneumonia: where should the priority lie? Source: Eur Respir J 2016; 48: 619-622 Year: 2016